Money Minute: CBS's 'Big Bang' Dilemma; Coke Gambles on Homemade Soda

The NFL carries a bigger bang than "The Big Bang Theory." The NFL has awarded a series of extra games for next season to CBS (CBS). In addition to the Sunday afternoon AFC games it already carries, the network will broadcast the first 8 Thursday night games of the season.

The deal means CBS will have to find a temporary new home for one of its most popular sitcoms, "The Big Bang Theory." But the other 8 Thursday games will still be shown on the NFL Network, which is a premium priced channel on most cable systems. CBS will also get a pair of late season Saturday games.

First Coke came in a bottle, then a can, and soon in a little plastic pod. Coca-Cola (KO) has inked a $1.3 billion deal for Green Mountain Coffee Roasters (GMCR) to create an in-home system for cold beverages. Like its Keurig coffeemakers and K-Cup packs, the Vermont-based company will produce single-serve cold drinks.

Twitter's (TWTR) first quarterly earnings since going public last year were good, but not good enough. Revenue more than doubled, %VIRTUAL-article-sponsoredlinks%but Twitter remains unprofitable -- and the company's pace of growth seems to be slowing. I can tell you in less than 140 characters: the stock is set to slide today.

The Dow Jones industrial average (^DJI) edged lower Wednesday, losing 5 points. We haven't seen back-to-back gains in more than three weeks. The Nasdaq composite (^IXIC) fell 20 and the Standard & Poor's 500 index (^GPSC) slipped 3 points.

It's getting harder to find free checking. The Wall Street Journal reports that more lenders are imposing fees. In fact, 41 percent of U.S. banks no longer offer free checking accounts. That's up from 33 percent just a year ago. What's more, consumers with lower bank balances are likely to be hit the hardest.

Boehringer Ingelheim, the German maker of Pradaxa, has reportedly tried to hide internal documents that show the blood-thinning drug can cause fatal bleeding. Pradaxa, which has been taken by 850,000 patients since being approved in 2010, has now been linked to more than 1,000 deaths.

-Produced by Drew Trachtenberg.